As the demand for COVID-19 diagnostic tests soar, the FDA guidelines around emergency-use authorization continue to shift. In this 30-minute webinar, Jo-Ann Gonzales, RAC, Director, IVD Regulatory & Quality Consulting, Precision for Medicine, shares what has changed, provides 2 example case studies, and offers 5 key takeaways for those seeking FDA approval.